Archive - September 2019
Vertex eyes type 1 diabetes cure with biotech acquisition
Cidara, Mundipharma team up to commercialise Rezafungin
Teva undergoes rebranding
Women ‘risking’ lives, not doing bowel screening tests
UK in ‘desperate’ need of thousands more GPs
ABPI launches NHS, industry partnership guideline
NICE nod for Novartis’ Luxturna
NICE backs NHS use of Novartis’ gene therapy Luxturna